Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 3: Prevention of osteoporosis and CV effects of estrogens and antiestrogens.
D015519:Bone Density / Q000187:drug effects; D001943:Breast Neoplasms / Q000150:complications*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D004164:Diphosphonates / Q000494:pharmacology / Q000627:therapeutic use*; D004965:Estrogen Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*
D004164:Diphosphonates; D004965:Estrogen Antagonists